RxDoctor Payments Data

Andrea Baratta, DO

Dermatology · Mount Laurel, NJNPI 1124080619

Payments from drug & device makers

$3,137in general payments, 2019–2025

Across 141 payments — averaging $22.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$532
  • Johnson & Johnson$379
  • Sun Pharmaceutical Industries Inc.$372
  • Lilly USA, LLC$213
  • AbbVie$186
  • Novartis$181
  • plus $1K from 20 others

What the payments were for

  • Speaking & faculty fees$45014%
  • Food & beverage$2,28773%
  • Education$40013%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,137 in reported general payments places this provider in the 55th percentile of 394 dermatology providers in New Jersey.

See all dermatology providers in New Jersey

Medicare billing

Part B allowed, 2024
$108,394
Medicare patients
420
Services billed
1,307

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab15$129,033
Taltz AutoinjectorIxekizumab14$106,912
OtezlaApremilast13$61,840
Dupixent SyringeDupilumab14$52,180
Clobetasol Propionate41$1,393
Betamethasone Dipropionate22$1,044
Tretinoin14$1,033
Triamcinolone Acetonide75$866
Halobetasol Propionate21$831
Metronidazole13$581
ValacyclovirValacyclovir Hcl11$551
Gentamicin Sulfate11$384
Ketoconazole17$362
Imiquimod11$281
Doxycycline Monohydrate20$278

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$16$61,84013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 394 dermatology providers in New Jersey.

Other dermatology in Mount Laurel

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →